Abstract
A group at Johns Hopkins University has been monitoring free-floating tumor DNA in blood to track cancer. A new study being published in
Science Translational Medicine
this week suggests that advances in DNA sequencing may make this approach more viable.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献